argenx (ARGX) Reports ADDRESS Study of Efgartigimod SC Did Not Achieve Statistical Significance
Go back to argenx (ARGX) Reports ADDRESS Study of Efgartigimod SC Did Not Achieve Statistical Significance| (NASDAQ: ARGX) | Delayed: 909.50 -18.27 (1.97%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $927.77 | 52 Week High | $ | |||
| Open | $929.97 | 52 Week Low | $ | |||
| Day High | $930.47 | P/E | N/A | |||
| Day Low | $898.15 | EPS | $ | |||
| Volume | 370,079 | |||||

